as of Oct 23
HUM
GrowthHUMANA INC
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers.
Close · 3M
+11.00%
Held by 2 AI ETFs
as of Oct 16
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
AMOM · Weight increase · 2d
weight 1.440% → 1.560% (+0.120 pp)·stock up 12.3% in the 30 days before
Oct 15·entry $432.20·now $422.07Fresh
AMOM · Weight increase · 2d
weight 1.310% → 1.480% (+0.170 pp)·stock up 5.8% in the 30 days before
Oct 12·entry $433.50·now $422.07Fresh
AMOM · Weight decrease · 3d
weight 1.350% → 1.310% (-0.040 pp)·stock down 3.2% in the 30 days before
Oct 8·entry $387.12·now $422.07
AMOM · Weight decrease · 2d
weight 1.350% → 1.320% (-0.030 pp)·stock down 1.6% in the 30 days before
Oct 7·entry $396.51·now $422.07
AMOM · Weight increase · 2d
weight 1.290% → 1.350% (+0.060 pp)·stock down 0.6% in the 30 days before
Oct 5·entry $404.07·now $422.07Drifting
AMOM · Weight decrease · 4d
weight 1.370% → 1.290% (-0.080 pp)·stock down 3.8% in the 30 days before
Oct 1·entry $379.68·now $422.07
AMOM · Weight decrease · 3d
weight 1.370% → 1.320% (-0.050 pp)·stock down 0.4% in the 30 days before
Sep 30·entry $381.57·now $422.07
AMOM · Weight decrease · 2d
weight 1.370% → 1.330% (-0.040 pp)·stock up 0.3% in the 30 days before
Sep 29·entry $386.87·now $422.07
AMOM · Weight increase · 3d
weight 1.280% → 1.370% (+0.090 pp)·stock up 1.8% in the 30 days before
Sep 25·entry $397.93·now $422.07Drifting
AMOM · Weight increase · 2d
weight 1.280% → 1.310% (+0.030 pp)·stock down 2.4% in the 30 days before
Sep 24·entry $380.32·now $422.07Chased
AMOM · Weight decrease · 6d
weight 1.490% → 1.280% (-0.210 pp)·stock down 1.8% in the 30 days before
Sep 22·entry $372.00·now $422.07
AMOM · Weight decrease · 5d
weight 1.490% → 1.310% (-0.180 pp)·stock down 0.6% in the 30 days before
Sep 21·entry $378.58·now $422.07
AMOM · Weight decrease · 4d
weight 1.490% → 1.360% (-0.130 pp)·stock up 2.2% in the 30 days before
Sep 18·entry $386.22·now $422.07
AMOM · Weight decrease · 3d
weight 1.490% → 1.370% (-0.120 pp)·stock up 0.7% in the 30 days before
Sep 17·entry $384.52·now $422.07
AMOM · Weight decrease · 2d
weight 1.490% → 1.400% (-0.090 pp)·stock up 0.1% in the 30 days before
Sep 16·entry $384.72·now $422.07
AMOM · Weight increase · 3d
weight 1.420% → 1.490% (+0.070 pp)·stock up 5.7% in the 30 days before
Sep 14·entry $407.02·now $422.07Drifting
AMOM · Weight increase · 2d
weight 1.420% → 1.460% (+0.040 pp)·stock up 5.4% in the 30 days before
Sep 11·entry $409.80·now $422.07Drifting
AMOM · Weight decrease · 2d
weight 1.480% → 1.420% (-0.060 pp)·stock up 4.7% in the 30 days before
Sep 8·entry $403.09·now $422.07
AIVL · Weight increase · 2d
stock up 10.3% in the 30 days before
Jul 14·entry $406.77·now $422.07Drifting
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.
Buffett-style framework
AIUP opened a new 4.61% position on 2026-10-16, AMOM has been gradually accumulating with small back-and-forth moves up to 1.56%, and QRFT holds a token 0.11%. This conflicts with a Too Hard verdict, since the AIs are buying a business whose earnings depend on regulatory and cost-trend outcomes that this framework declines to forecast. The buying looks more like a bet on earnings recovery or momentum than a margin-of-safety purchase.
- Circle of CompetenceMedicare Advantage earnings hinge on annual government rate-setting, star-rating outcomes and medical cost trends that have swung sharply in recent years, so ten-year cash flows are hard to project and the company falls outside a reasonable circle of competence.
- Economic MoatNot scored because the business was judged too hard to model at Stage 1.
- ManagementNot scored because the business was judged too hard to model at Stage 1.
- Financial HealthNot scored, though the 6.92% ROE visible in the data is already well below the 15% benchmark.
- Margin of SafetyNot scored, though a 40.9 PER and 30.6 EV/EBITDA on depressed earnings offer no obvious margin of safety.
Humana's earnings power rests on government payment rates and volatile medical costs, so it fails the circle of competence test and is not scored further. The visible numbers, including a 6.92% ROE and very high earnings multiples, would also be hard to reconcile with the framework's return and price standards. This is an educational interpretation, not investment advice.
Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.